Helicobacter pylori and hematological disorders.

Area of Science:

• Gastroenterology and Hematology
• Infectious Diseases
• Microbiology

Background:

• Helicobacter pylori (H. pylori) is a prevalent global infection impacting the upper gastrointestinal tract.
• Associated conditions extend beyond gastrointestinal issues to include hematological disorders like iron deficiency anemia, immune thrombocytopenia, and vitamin B12 deficiency.
• These H. pylori-hematologic disorder links are recognized in major consensus reports.

Purpose of the Study:

• To review the hematologic diseases associated with H. pylori infection.
• To discuss the pathogenic mechanisms, particularly for MALT lymphoma and other hematologic conditions.
• To highlight the therapeutic implications of H. pylori eradication for these disorders.

Main Methods:

• Literature review focusing on H. pylori and associated hematologic conditions.
• Analysis of pathogenic mechanisms linking H. pylori to anemia, vitamin B12 deficiency, immune thrombocytopenia, and MALT lymphoma.
• Evaluation of treatment outcomes, specifically the hematologic response to H. pylori eradication therapy.

Main Results:

• H. pylori infection is strongly associated with iron deficiency anemia, vitamin B12 deficiency, and immune thrombocytopenia.
• Pathogenic mechanisms for H. pylori-induced hematologic disorders are not fully elucidated but eradication therapy shows efficacy.
• H. pylori eradication is a primary treatment for localized gastric MALT lymphoma.

Conclusions:

• H. pylori plays a significant role in several hematologic diseases.
• Further research is needed to clarify the precise pathogenic links between H. pylori and hematologic disorders.
• H. pylori eradication is a crucial therapeutic strategy for associated hematologic conditions and MALT lymphoma.